186 related articles for article (PubMed ID: 37544346)
1. Fuzheng Huayu recipe alleviates liver fibrosis via inhibiting NLRP3 inflammasome activation in macrophages.
Ping D; Qi J; Li M; Sun X; Peng Y; Liu C
J Ethnopharmacol; 2024 Jan; 318(Pt B):117001. PubMed ID: 37544346
[TBL] [Abstract][Full Text] [Related]
2. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.
Inzaugarat ME; Johnson CD; Holtmann TM; McGeough MD; Trautwein C; Papouchado BG; Schwabe R; Hoffman HM; Wree A; Feldstein AE
Hepatology; 2019 Feb; 69(2):845-859. PubMed ID: 30180270
[TBL] [Abstract][Full Text] [Related]
3. Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome.
Niu WX; Bao YY; Zhang N; Lu ZN; Ge MX; Li YM; Li Y; Chen MH; He HW
Bioorg Chem; 2022 Oct; 127():105971. PubMed ID: 35749855
[TBL] [Abstract][Full Text] [Related]
4. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.
Tao YY; Yan XC; Zhou T; Shen L; Liu ZL; Liu CH
BMC Complement Altern Med; 2014 Nov; 14():449. PubMed ID: 25407538
[TBL] [Abstract][Full Text] [Related]
5. [Action mechanism and active components of Fuzheng Huayu Recipe against liver fibrosis via regulating macrophage with network pharmacology and transcriptomics methods].
Xing L; Hu XD; Tao YY; Peng Y; Liu CH
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(11):3029-3037. PubMed ID: 35718527
[TBL] [Abstract][Full Text] [Related]
6. Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-β/NLRP3 inflammasome pathway.
Lin L; Zhou M; Que R; Chen Y; Liu X; Zhang K; Shi Z; Li Y
Biochem Cell Biol; 2021 Oct; 99(5):666-674. PubMed ID: 33974808
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages
Wang Y; Wang C; He Q; Chen G; Yu J; Cang J; Zhong M
Front Immunol; 2023; 14():1090202. PubMed ID: 36798132
[TBL] [Abstract][Full Text] [Related]
8. Prim-O-glucosycimifugin attenuates liver injury in septic mice by inhibiting NLRP3 inflammasome/caspase-1 signaling cascades in macrophages.
Liu LL; Yan X; Xue KY; Wang XM; Li LY; Chen HY; Li RL; Li H; Lan J; Xin JJ; Li X; Zhuo CL; Wu Z; Zhang D; Huang WJ; Wang YL; Li XY; Jiang W; Zhang HY
Phytomedicine; 2022 Nov; 106():154427. PubMed ID: 36088791
[TBL] [Abstract][Full Text] [Related]
9. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis.
Kaufmann B; Kui L; Reca A; Leszczynska A; Kim AD; Booshehri LM; Wree A; Friess H; Hartmann D; Broderick L; Hoffman HM; Feldstein AE
Cell Mol Gastroenterol Hepatol; 2022; 14(4):751-767. PubMed ID: 35787975
[TBL] [Abstract][Full Text] [Related]
11. Sapidolide A alleviates acetaminophen-induced acute liver injury by inhibiting NLRP3 inflammasome activation in macrophages.
Wang JC; Shi Q; Zhou Q; Zhang LL; Qiu YP; Lou DY; Zhou LQ; Yang B; He QJ; Weng QJ; Wang JJ
Acta Pharmacol Sin; 2022 Aug; 43(8):2016-2025. PubMed ID: 35022542
[TBL] [Abstract][Full Text] [Related]
12. Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome.
Kim HY; Choi YJ; Kim SK; Kim H; Jun DW; Yoon K; Kim N; Hwang J; Kim YM; Lim SC; Kang KW
Commun Biol; 2021 Jun; 4(1):824. PubMed ID: 34193972
[TBL] [Abstract][Full Text] [Related]
13. Isomaculosidine facilitates NLRP3 inflammasome activation by promoting mitochondrial reactive oxygen species production and causes idiosyncratic liver injury.
Shi W; Liu T; Yang H; Zhao J; Wei Z; Huang Y; Li Z; Li H; Liang L; Hou X; Chen Y; Gao Y; Bai Z; Xiao X
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117063. PubMed ID: 37598766
[TBL] [Abstract][Full Text] [Related]
14. Two-pore potassium channel TREK-1 (K2P2.1) regulates NLRP3 inflammasome activity in macrophages.
Immanuel CN; Teng B; Dong BE; Gordon EM; Luellen C; Lopez B; Harding J; Cormier SA; Fitzpatrick EA; Schwingshackl A; Waters CM
Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L367-L376. PubMed ID: 38252657
[TBL] [Abstract][Full Text] [Related]
15. [Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway].
Wang QL; Tao YY; Shen L; Cui HY; Liu CH
Zhong Xi Yi Jie He Xue Bao; 2012 May; 10(5):561-8. PubMed ID: 22587979
[TBL] [Abstract][Full Text] [Related]
16. Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis.
Zhou X; Fu Y; Chen J; Liu P
J Ethnopharmacol; 2024 Jun; 327():118018. PubMed ID: 38453100
[TBL] [Abstract][Full Text] [Related]
17. Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome.
Li Y; Zhang Y; Chen T; Huang Y; Zhang Y; Geng S; Li X
J Gastroenterol Hepatol; 2020 Jun; 35(6):1069-1077. PubMed ID: 31860730
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice.
Jiang C; Iwaisako K; Cong M; Diggle K; Hassanein T; Brenner DA; Kisseleva T
Arch Clin Biomed Res; 2020; 4(5):561-580. PubMed ID: 33210080
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes.
Liu L; Wei Y; Xie N; Cai H; Lin Y
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):183-188. PubMed ID: 38430023
[TBL] [Abstract][Full Text] [Related]
20. Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.
Choi J; Cho Y; Choi H; Lee S; Han H; Lee J; Kwon J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
